IRIS Institutional Research Information System - OPENBS Open Archive UniBS

LAGANÀ, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.726
AS - Asia 1.843
EU - Europa 1.503
SA - Sud America 309
AF - Africa 44
OC - Oceania 4
Totale 6.429
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.653
SG - Singapore 786
CN - Cina 456
IT - Italia 390
BR - Brasile 251
PL - Polonia 250
FI - Finlandia 200
HK - Hong Kong 180
VN - Vietnam 169
DE - Germania 161
GB - Regno Unito 92
FR - Francia 73
IE - Irlanda 61
TR - Turchia 60
RU - Federazione Russa 57
UA - Ucraina 56
IN - India 40
BD - Bangladesh 35
CA - Canada 35
SE - Svezia 33
NL - Olanda 29
ID - Indonesia 26
MX - Messico 24
AR - Argentina 21
CZ - Repubblica Ceca 18
ZA - Sudafrica 17
ES - Italia 15
BE - Belgio 14
IQ - Iraq 14
JP - Giappone 14
AT - Austria 10
CH - Svizzera 10
EC - Ecuador 10
DZ - Algeria 8
PH - Filippine 8
PK - Pakistan 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
SA - Arabia Saudita 7
PT - Portogallo 6
BG - Bulgaria 5
CO - Colombia 5
CR - Costa Rica 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
LB - Libano 4
AU - Australia 3
ET - Etiopia 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
RO - Romania 3
AZ - Azerbaigian 2
CY - Cipro 2
GY - Guiana 2
HN - Honduras 2
KZ - Kazakistan 2
MK - Macedonia 2
MY - Malesia 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
EE - Estonia 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 6.429
Salva come PNG Salva come JPEG
Città #
Singapore 428
Ashburn 314
Warsaw 246
Dallas 236
San Jose 236
Hong Kong 180
Helsinki 148
Fairfield 121
New York 114
Los Angeles 110
Beijing 107
Chandler 92
The Dalles 79
Chicago 70
Munich 62
Council Bluffs 61
Ho Chi Minh City 54
Wilmington 53
Seattle 52
Brescia 48
Istanbul 46
Lauterbourg 46
Princeton 45
Houston 44
Milan 44
Woodbridge 43
Dalmine 39
Cambridge 38
Boardman 36
Jacksonville 36
Turku 35
Buffalo 33
Redondo Beach 30
Secaucus 30
Hanoi 29
Dublin 27
Moscow 26
Shanghai 26
Jakarta 25
Dong Ket 24
Salt Lake City 24
Orem 23
Santa Clara 23
Menlo Park 22
San Francisco 22
London 21
São Paulo 20
West Jordan 20
Des Moines 19
Bergamo 18
Poplar 18
Naples 17
Nuremberg 17
Lappeenranta 16
Ann Arbor 15
Brno 15
Rome 15
Stockholm 15
Brussels 14
Elk Grove Village 14
Rio de Janeiro 14
Boston 13
Brooklyn 13
Johannesburg 13
Amsterdam 11
Atlanta 11
Frankfurt am Main 11
Montreal 11
Romola 11
Tampa 11
Pune 10
Tokyo 10
Manchester 9
Phoenix 9
Biên Hòa 8
Chennai 8
Da Nang 8
Paris 8
Tianjin 8
Toronto 8
Turin 8
Brasília 7
Denver 7
Dulles 7
Düsseldorf 7
New Delhi 7
San Diego 7
Ankara 6
Curitiba 6
Dearborn 6
Dhaka 6
Guangzhou 6
Livorno 6
Raleigh 6
Sterling 6
São Bernardo do Campo 6
Haiphong 5
Hangzhou 5
Jinan 5
Mumbai 5
Totale 4.210
Salva come PNG Salva come JPEG
Nome #
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 378
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 251
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 221
Immunotherapy failure in adrenocortical cancer: where next? 220
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 197
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 179
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 178
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 177
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 169
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 138
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 131
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 130
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 130
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 128
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 125
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 123
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 122
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 121
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 120
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 116
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 115
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 113
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 112
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 110
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 109
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 107
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 107
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 105
Oncological treatment administration at end of life: a retrospective study 104
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 103
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 102
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 100
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 99
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 97
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 97
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 95
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 94
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 94
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 90
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 89
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 87
Adjuvant denosumab for early breast cancer-Evidence and controversy 81
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 80
The Evolving Treatment Landscape of Medullary Thyroid Cancer 79
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 79
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 69
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 69
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 67
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 55
Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis 54
null 51
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 47
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 44
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis 40
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 37
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 35
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 30
Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort 22
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study 22
Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen 18
The role of 2-[18F]FDG PET/CT in adrenocortical carcinoma: a systematic review 17
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 17
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 17
Oligometastatic adrenocortical carcinoma: definition and treatment 17
Primary Adrenal Malignancies 10
Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases 7
Quality of life questionnaire development and validation for adrenocortical carcinoma patients 6
Totale 6.553
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.138
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021121 0 0 0 0 0 0 0 0 0 52 26 43
2021/2022275 20 10 7 66 15 12 13 11 13 36 23 49
2022/2023249 31 16 18 15 19 51 4 27 26 8 17 17
2023/2024595 25 19 45 53 55 97 19 32 86 39 15 110
2024/20251.594 51 31 20 266 140 90 114 67 193 90 393 139
2025/20263.076 238 361 376 349 305 247 475 177 265 283 0 0
Totale 6.553